Microvascular and macrovascular disease and risk for major peripheral arterial disease in patients with type 2 diabetes

Diabetes Care

Volumn 39, Issue 10, 2016, Pages 1796-1803

  Mohammedi, Kamel ^a   Woodward, Mark ^a,b,c   Hirakawa, Yoichiro ^a   Zoungas, Sophia ^a,d   Williams, Bryan ^e   Lisheng, Liu ^f   Rodgers, Anthony ^a   Mancia, Giuseppe ^g   Neal, Bruce ^a   Harrap, Stephen ^h   Marre, Michel ^i,j,k   Chalmers, John ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d MONASH UNIVERSITY   (Australia)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f Chinese Hypertension League Institute   (China)

^g UNIVERSITY OF MILANO BICOCCA   (Italy)

^h UNIVERSITY OF MELBOURNE   (Australia)

ⁱ CENTRE DE RECHERCHE DES CORDELIERS   (France)

^j BICHAT HOSPITAL   (France)

^k UNIVERSITÉ PARIS DESCARTES   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; DRUG COMBINATION; GLICLAZIDE; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; INDAPAMIDE; INDAPAMIDE, PERINDOPRIL DRUG COMBINATION; PERINDOPRIL;

AGE; AGED; ANALYTICAL PARAMETERS; ANGIOPLASTY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; COUNTRY ECONOMIC STATUS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE DURATION; DRUG USE; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; FOLLOW UP; GENDER; HUMAN; LASER COAGULATION; LEG AMPUTATION; LEG ULCER; MACROALBUMINURIA; MACROVASCULAR DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MICROANGIOPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PERIPHERAL VASCULAR DISEASE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETINAL PHOTOCOAGULATION THERAPY; RISK ASSESSMENT; RISK FACTOR; SMOKING; SYSTOLIC BLOOD PRESSURE; URINARY ALBUMIN TO CREATININE RATIO; BIOASSAY; CLINICAL TRIAL; COMPLICATION; DIABETES MELLITUS, TYPE 2; DRUG COMBINATION; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL;

AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DRUG COMBINATIONS; ENDPOINT DETERMINATION; FEMALE; FOLLOW-UP STUDIES; GLICLAZIDE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INDAPAMIDE; MALE; MIDDLE AGED; PERINDOPRIL; PERIPHERAL ARTERIAL DISEASE; PROPORTIONAL HAZARDS MODELS; RISK FACTORS;

EID: 84988954344     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc16-0588     Document Type: Article

References (39)

1. Tancredi M, Rosengren A, Svensson AM, et al. Excess mortality among persons with type 2 diabetes. N Engl J Med 2015;373:1720-1732
2. Almdal T, Scharling H, Jensen JS, Vestergaard H. The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: A population-based study of 13,000 men and women with 20 years of follow-up. Arch Intern Med 2004;164:1422-1426
3. Emdin CA, Anderson SG, Callender T, et al. Usual blood pressure, peripheral arterial disease, and vascular risk: Cohort study of 4.2 million adults. BMJ 2015;351:h4865
4. Fowkes FG, Rudan D, Rudan I, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: A systematic review and analysis. Lancet 2013;382:1329-1340
5. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: Results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 2004;110:738-743
6. Patel A, MacMahon S, Chalmers J, et al.; ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560-2572
7. Jude EB, Oyibo SO, Chalmers N, Boulton AJ. Peripheral arterial disease in diabetic and nondiabetic patients: A comparison of severity and outcome. Diabetes Care 2001;24:1433-1437
8. Norman PE, Davis WA, Bruce DG, Davis TM. Peripheral arterial disease and risk of cardiac death in type 2 diabetes: The Fremantle Diabetes Study. Diabetes Care 2006;29:575-580
9. Abbott JD, Lombardero MS, Barsness GW, et al. Ankle-brachial index and cardiovascular outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial. Am Heart J 2012;164:585-590
10. van der Feen C, Neijens FS, Kanters SD,Mali WP, Stolk RP, Banga JD. Angiographic distribution of lower extremity atherosclerosis in patients with and without diabetes. Diabet Med 2002;19:366-370
11. ADVANCE Management Committee. Study rationale and design of ADVANCE: Action in Diabetes and Vascular DiseasedPreterax and Diamicron MR Controlled Evaluation. Diabetologia 2001;44:1118-1120
12. Patel A, MacMahon S, Chalmers J, et al.; ADVANCE Collaborative Group. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): A randomised controlled trial. Lancet 2007;370:829-840
13. Sebastianski M, Makowsky MJ, Dorgan M, Tsuyuki RT. Paradoxically lower prevalence of peripheral arterial disease in South Asians: A systematic review and meta-analysis. Heart 2014;100:100-105
14. Althouse AD, Abbott JD, Forker AD, et al.; BARI 2D Study Group. Risk factors for incident peripheral arterial disease in type 2 diabetes: Results from the Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes (BARI 2D) Trial. Diabetes Care 2014;37:1346-1352
15. Fiordaliso F, Clerici G, Maggioni S, et al. Prospective study on microangiopathy in type 2 diabetic foot ulcer. Diabetologia 2016;59:1542-1548
16. de Zeeuw D, Parving HH, Henning RH. Microalbuminuria as an early marker for cardiovascular disease. J Am Soc Nephrol 2006;17: 2100-2105
17. Miettinen H, Haffner SM, Lehto S, Rönnemaa T, Pyöräl à K, Laakso M. Retinopathy predicts coronary heart disease events in NIDDM patients. Diabetes Care 1996;19:1445-1448
18. Cheung N, Rogers S, Couper DJ, Klein R, Sharrett AR, Wong TY. Is diabetic retinopathy an independent risk factor for ischemic stroke?. Stroke 2007;38:398-401
19. Targher G, Bertolini L, Zenari L, et al. Diabetic retinopathy is associated with an increased incidence of cardiovascular events in type 2 diabetic patients. Diabet Med 2008;25: 45-50
20. Kramer CK, Rodrigues TC, Canani LH, Gross JL, Azevedo MJ. Diabetic retinopathy predicts allcause mortality and cardiovascular events in both type 1 and 2 diabetes: Meta-analysis of observational studies. Diabetes Care 2011;34:1238-1244
21. Taniwaki H, Shoji T, Emoto M, et al. Femoral artery wall thickness and stiffness in evaluation of peripheral vascular disease in type 2 diabetes mellitus. Atherosclerosis 2001;158:207-214
22. Kizu A, Koyama H, Tanaka S, et al. Arterial wall stiffness is associated with peripheral circulation in patients with type 2 diabetes. Atherosclerosis 2003;170:87-91
23. Cardoso CR, Ferreira MT, Leite NC, Barros PN, Conte PH, Salles GF. Microvascular degenerative complications are associated with increased aortic stiffness in type 2 diabetic patients. Atherosclerosis 2009;205:472-476
24. Dart AM, Kingwell BA. Pulse pressureda review of mechanisms and clinical relevance. J Am Coll Cardiol 2001;37:975-984
25. Suzuki E, Kashiwagi A, Nishio Y, et al. Increased arterial wall stiffness limits flow volume in the lower extremities in type 2 diabetic patients. Diabetes Care 2001;24:2107-2114
26. Smith A, Karalliedde J, De Angelis L, Goldsmith D, Viberti G. Aortic pulse wave velocity and albuminuria in patients with type 2 diabetes. J Am Soc Nephrol 2005;16:1069-1075
27. Bouchi R, Babazono T, Mugishima M, et al. Arterial stiffness is associated with incident albuminuria and decreased glomerular filtration rate in type 2 diabetic patients. Diabetes Care 2011;34:2570-2575
28. Liu JJ, Tavintharan S, Yeoh LY, et al. High normal albuminuria is independently associated with aortic stiffness in patients with type 2 diabetes. Diabet Med 2014;31:1199-1204
29. Rema M, Mohan V, Deepa R, Ravikumar R; Chennai Urban Rural Epidemiology Study-2. Association of carotid intima-media thickness and arterial stiffness with diabetic retinopathy: The Chennai Urban Rural Epidemiology Study (CURES-2). Diabetes Care 2004;27:1962-1967
30. Lim LS, Ling LH, Cheung CM, et al. Relationship of systemic endothelial function and peripheral arterial stiffness with diabetic retinopathy. Br J Ophthalmol 2015;99:837-841
31. Adler AI, Stevens RJ, Neil A, Stratton IM, Boulton AJ, Holman RR. UKPDS 59: Hyperglycemia and other potentiallymodifiable risk factors for peripheral vascular disease in type 2 diabetes. Diabetes Care 2002;25:894-899
32. Frye RL, August P, Brooks MM, et al.; BARI 2D Study Group. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med 2009;360:2503-2515
33. Jones WS, Patel MR, Rockman CB, et al. Association of the ankle-brachial index with history of myocardial infarction and stroke. Am Heart J 2014;167:499-505
34. Potier L, Abi Khalil C, Mohammedi K, Roussel R. Use and utility of ankle brachial index in patients with diabetes. Eur J Vasc Endovasc Surg 2011;41:110-116
35. Hata J, Arima H, Zoungas S, et al.; ADVANCE Collaborative Group. Effects of the endpoint adjudication process on the results of a randomised controlled trial: The ADVANCE trial. PLoS One 2013;8:e55807
36. Tzoulaki I, Murray GD, Price JF, et al. Hemostatic factors, inflammatorymarkers, and progressive peripheral atherosclerosis: The Edinburgh Artery Study. Am J Epidemiol 2006;163:334-341
37. Pradhan AD, Shrivastava S, Cook NR, Rifai N, Creager MA, Ridker PM. Symptomatic peripheral arterial disease in women: nontraditional biomarkers of elevated risk. Circulation 2008; 117:823-831
38. Ho DY, Cook NR, Britton KA, et al. Highmolecular- weight and total adiponectin levels and incident symptomatic peripheral artery disease in women: A prospective investigation. Circulation 2011;124:2303-2311
39. Fowkes FG, Murray GD, Butcher I, et al.; Ankle Brachial Index Collaboration. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: A meta-analysis. JAMA 2008;300:197-208